Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19
Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of Inpatients During the COVID-19 Outbreak: A Prospective Cohort Study
Sponsor: Haukeland University Hospital
A observational or N/A phase clinical study on SARS Virus and Severe Acute Respiratory Syndrome, this trial is ongoing. The trial is conducted by Haukeland University Hospital and has accumulated 8 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Feb 2024 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Dec 2021 — Feb 2024 [monthly]
Recruiting
-
Oct 2021 — Dec 2021 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jun 2020 — Nov 2020 [monthly]
Recruiting
First recorded
Mar 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Haukeland University Hospital
- Oslo University Hospital
- Ostfold Hospital Trust
- St. Olavs Hospital
- University Hospital of North Norway
- University Hospital, Akershus
- Vestre Viken Hospital Trust
For direct contact, visit the study record on ClinicalTrials.gov .